Silvercrest Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,860
Closed -$207K 866
2021
Q1
$207K Buy
+3,860
New +$222K ﹤0.01% 802
2020
Q4
Sell
-171,323
Closed -$5.57M 832
2020
Q3
$5.57M Sell
171,323
-283
-0.2% -$8.99K 0.05% 319
2020
Q2
$4.45M Sell
171,606
-31,762
-16% -$791K 0.04% 346
2020
Q1
$4.94M Sell
203,368
-439
-0.2% -$11.1K 0.05% 275
2019
Q4
$5.69M Sell
203,807
-8,714
-4% -$226K 0.04% 324
2019
Q3
$5.1M Buy
+212,521
New +$5.65M 0.04% 332

Other funds holding VCYT

Silvercrest Asset Management's VCYT Position: Q2 2021 in Review

Silvercrest Asset Management sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 3,860 shares — an estimated $207K sold.

Silvercrest Asset Management first reported a position in VCYT in Q3 2019 and held it in 6 quarters. The position peaked at $5.69M in Q4 2019. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Silvercrest Asset Management reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Silvercrest Asset Management sold 3,860 Veracyte shares in Q2 2021, an estimated $207K.
  • Silvercrest Asset Management first reported a position in Veracyte in Q3 2019 and held it in 6 quarters.
  • Silvercrest Asset Management's Veracyte position peaked at $5.69M in Q4 2019.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Silvercrest Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.